Ranbaxy Laboratories
May 28, 2012 at 11:26 | Source: Moneycontrol.com
May 23, 2012 at 15:00 | Source: CNBC-TV18
May 17, 2012 at 15:38 | Source: Moneycontrol.com
May 17, 2012 at 10:12 | Source: Reuters
May 15, 2012 at 15:05 | Source: Moneycontrol.com
May 11, 2012 at 15:50 | Source: CNBC-TV18
News across the web »
May 28, 2012 at 11:11 | Source: Economic Times
May 28, 2012 at 04:51 | Source: Economic Times
May 25, 2012 at 16:22 | Source: The Hindu BusinessLine
May 25, 2012 at 09:31 | Source: Economic Times
May 23, 2012 at 12:21 | Source: Economic Times
Interact & exchange stock tips & market info »
Related News »
Ranbaxy Laboratories is going to launch Cipher Pharma's Absorica in US in October-December. The company will make USD 9 million milestone payment to Cipher for Absorica, reports CNBC-TV18. It touched an intraday high of Rs 537.00 and an intraday ...
May 28, 2012 at 05:59 | Source: MoneyControl.com
Tokyo, May 25 (PTI) Drug major Ranbaxy Laboratories today said it has hired two US-based consultants to advise it on remedial work to be done at its manufacturing units in India as part of a consent decree signed with the USFDA to revoke ban imposed by the ...
May 25, 2012 at 09:30 | Source: MSN India
"We look forward to working closely with our partner, Ranbaxy Laboratories Inc., in preparation for the upcoming U.S. launch of the product through its dermatology sales force." "We are thrilled to make Absorica available as a valuable option ...
May 28, 2012 at 03:28 | Source: Yahoo Finance
Emkay Global Financial Services is bullish on Ranbaxy Laboratories and has recommended buy rating on the stock with a target price of Rs 559 in its May 09, 2012 research report. "Ranbaxy Laboratories, Q1CY12 Results - Revenues at Rs37bn (up 73% ...
May 15, 2012 at 09:13 | Source: MoneyControl.com
May 9 (Reuters) - Ranbaxy Laboratories, India's top drugmaker by sales, reported a four-fold rise in quarterly net profit, helped by sales of its generic version of cholesterol drug Lipitor in its key U.S. market, sending its shares up more than ...
May 9, 2012 at 09:49 | Source: Reuters
ACCRA: Leading Indian drug manufacturer Ranbaxy Laboratories has boosted its presence in the emerging market of Africa, introducing its new malaria-fighting drug Synriam and setting up manufacturing facilities in Morocco, Nigeria and South Africa.
May 11, 2012 at 07:45 | Source: Express Buzz
Janssen Pharmaceuticals Inc., sued Germany-based Haupt Pharma AG's U.S. unit, Haupt Pharma Inc., as well as India-based Ranbaxy Laboratories Ltd. and its New Jersey-based unit, Ranbaxy Laboratories Inc. Janssen alleges the generics makers filed abbreviated ...
May 23, 2012 at 17:10 | Source: site.law360.com
Drug maker Ranbaxy Laboratories on Wednesday said its first-quarter consolidated net profit surged by 310 per cent to Rs 1,247 crore, from Rs 304 crore a year earlier, on strong growth in US sales. Net sales for the three months to March rose to Rs 3,695 ...
May 9, 2012 at 19:29 | Source: Business Standard
Synriam, a new anti-malaria drug developed by the leading Indian drug manufacturer Ranbaxy Laboratories was launched in Africa. The launching may help Ranbaxy to boost its presence in the emerging market of Africa and setting up manufacturing ...
May 12, 2012 at 08:05 | Source: Med India
Indian pharmaceutical firm, Ranbaxy Laboratories has reported a higher than expected results for the fourth quarter of the financial year till March 2012. The company's consolidated sales increased 55 per cent at Rs 3,700 crore during the fourth quarter of ...
May 9, 2012 at 13:52 | Source: Top News India